TP53 and cancer: In addition, our results show significant differences in genetic alterations in tumor driver genes (IDH1, PTEN, TP53, and ATRX) among the pyroptosis subtypes C1, C2, and C3, and many cancer-promoting pathways and immune-related processes were greatly enriched in the GPI-H group.